Ginkgo Bioworks IPO: Biotech Bringing Stock via $15 Billion SPAC Deal

The Ginkgo Bioworks IPO brings opportunity in the engineered biology market. And the company decided to offer stock via SPAC Soaring Eagle. Here’s what you need to know.